Seeking Alpha

More on CVS Caremark (CVS): Pharmacy Services sales up 28.2% Y/Y to $18.4B, led by new client...

More on CVS Caremark (CVS): Pharmacy Services sales up 28.2% Y/Y to $18.4B, led by new client starts and drug cost inflation. Retail Pharmacy 6.9% higher to $15.8B, with Walgreen-Express Scripts dispute impacting results. Raises and narrows full-year EPS to $3.32-$3.38, up from prior guidance of $3.23-$3.33. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|